IL-6基因多态性与变应性鼻炎的关联性

目的探讨白细胞介素6(IL-6)基因启动子区-634C/G和-572C/G位点多态性与变应性鼻炎的关联性。方法应用聚合酶链反应-限制性片段长度多态性法(PCR-RFLP)检测105例PHC患者和130例健康对照者IL-6基因启动子区-634和-572位点多态性。结果 IL-6基因-634C/G多态性在变应性鼻炎组和对照组的分布差异不显著性(P0.05),而IL-6基因-572C/G多态性在两组人群中的分布差异显著(P0.05)。等位基因频率的相对风险分析发现,G等位基因携带者患冠心病的风险是C等位基因的1.849倍[相对比值比(OR)=1.849,95%可信区间(CI):1.187～2.879]。结论 IL-6-572基因多态性与变应性鼻炎的发病有相关性,G等位基因可能是变应性鼻炎的遗传易感基因。     

辽西地区慢性心力衰竭患者IL-6基因的多态性

目的研究白细胞介素6(IL-6)-174位点和-634位点G/C多态性在辽西地区慢性心力衰竭(CHF)患者的多态性分布及相关性。方法应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)的方法,对80例慢性心力衰竭患者和健康对照组80例受试者,研究IL-6-174和IL-6-634位点基因多态性分布。结果 IL-6-634位点等位基因G、C频率对照组分别为13.13%、86.87%,CHF组分别为23.12%、76.88%,等位基因G在CHF组检出率明显高出对照组(0.05)。IL-6-174位点等位基因G、C频率对照组为98.13%、1.87%,CHF组为98.75%、1.25%,差异无统计学意义(0.05)。结论 IL-6-634 G多态性与CHF发病具有相关性,提示等位基因G可能是部分CHF患者易感性的遗传标志。     

白细胞介素-6基因多态性与卵巢癌的相关性研究

目的探讨白细胞介素-6(IL-6)基因启动子区域-174G/C基因多态性与中国北方汉族人卵巢癌的关系。方法采用序列特异性引物聚合酶链反应(PCR-SSP)技术,检测33例卵巢癌患者组和90例正常对照组IL-6基因多态性。结果IL-6基因-174G/C多态性位点基因型频率和等位基因频率在两组人群中的分布差异有统计学意义(x2=6.31,P<0.05),G等位基因携带者患卵巢癌的风险是C等位基因的3.74倍(OR=3.7405)。结论IL-6基因-174G/C多态性与卵巢癌的发病具有相关性,其中G等位基因可能是我国北方汉族人卵巢癌发病的遗传易感基因,携带G等位基因的个体可能通过促进IL-6的高度表达进而增加卵巢癌的发病风险。     

P53(rs1042522)基因多态性与子宫内膜异位症易感性的相关研究

目的 探讨肿瘤抑制基因P53 (tumor suppressor gene,P53)多态性与子宫内膜异位症(endometriosis,EM)遗传易感性的相关性.方法 应用等位基因特异性PCR技术结合DNA测序的方法对460例EM患者、650例无EM妇女(对照组)及113例子宫内膜癌患者的P53基因rs1042522位点(G/C)多态性进行分析.结果 各组均存在P53 (rs1042522) G/C多态性,且P53 (rs1042522)位点等位基因及基因型的分布在EM组与对照组之间差异有统计学意义(P值均小于0.01),其中等位基因C使EM发病风险提高1.179倍,等位基因G使其风险降低0.854倍；GC与GG基因型相比患EM的危险度增高1.548倍(95％CI为1.153～2.081),CC与GG基因型相比患EM的危险度增高1.865倍(95％CI为1.326～2.625).P53 (rs1042522)位点等位基因及基因型的分布在子宫内膜癌组与对照组之间差异有统计学意义(P值均小于0.01),且等位基因C使内膜癌发病风险提高1.278倍,而等位基因G使其风险降低0.772倍；GC与GG基因型相比患内膜癌的危险度增高2.074倍(95％CI为1.197～3.599),CC与GG基因型相比患内膜癌的危险度增高2.864倍(95％CI为1.557～5.263).P53 (rs1042522)位点等位基因及基因型的分布在EM组与子宫内膜癌组之间差异无统计学意义.结论 P53基因rs1042522位点(G/C)的单核苷酸多态性与EM遗传易感性存在相关性,且从遗传学角度分析,EM的发病机制可能更类似于肿瘤.     

IL-6基因启动子多态性与乳腺癌风险的关联性

目的:探讨白介素-6(IL-6)基因启动子区-597G/A(rs1800797)、-572C/G(rs1800796)和-174G/C(rs1800795)三个单核苷酸多态性位点(SNP)和乳腺癌易感性的关联性。方法:按照诊断标准,入组女性乳腺癌患者176例及年龄、体重指数等相匹配的健康女性200例。提取外周静脉血DNA,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术检测IL-6基因启动子区-597G/A、-572C/G和-174 G/C三个SNPs位点的基因型。利用SPSS11.5软件进行χ2检验,比较乳腺癌患者各位点基因型、等位基因频率与健康女性之间的差异,分析各位点多态性与乳腺癌发病风险的关联性。结果:IL-6基因-572C/G位点的基因型及等位基因频率分布在乳腺癌组与健康组之间存在显著性差异(P<0.05),乳腺癌组-572C/G位点的等位基因G频率显著高于健康组(χ2=15.438,P<0.0001,OR=2.017,95%CI=1.417～2.870)。结论:IL-6基因-572C/G位点多态性与乳腺癌易感性相关联,携带有-572G/C多态性位点G等位基因的女性罹患乳腺癌的风险要高于非携带女性。     

PDCD6基因多态性与子宫内膜异位症相关性分析

目的探讨中国汉族妇女PDCD6(程序性死亡细胞因子6)基因的单核苷酸多态性(SNP)与子宫内膜异位症(内异症)遗传易感性的相关性。方法收集2013年6月-2018年12月在我院就诊临床诊断并经手术治疗病理检查确诊的北方籍汉族妇女共225例内异症患者为内异症组和260例无内异症的妇女(对照组)的外周血,采用荧光定量PCR为基础的高分辨率熔解曲线分析(HRM)技术检测PDCD6基因的SNP,通过病例对照研究评估SNP与内异症的相关性。结果内异症组和对照组rs4957014位点等位基因G、T的频率分别为59.8%(311/520)、40.2%(209/520)和28%(126/450)、72%(324/450),GG、GT、TT基因型频率分别为43.8%(114/225)、31.9%(83/225)、24.3%(63/225)和8%(18/260)、40%(90/260)、52%(117/260),两组分别比较,携带等位基因T使内异症发病风险降低(OR=0.83,95%CI为0.67～0.92)。而rs3756712位点内异症组与对照组相比差异均大于0.05,无统计学意义。结论中国汉族妇女PDCD6基因rs4957014 位点多态性与内异症遗传易感性相关。     

白细胞介素-6基因多态性与再生障碍性贫血的相关研究

目的探讨白细胞介素-6（IL-6）基因启动子区域-174G/C基因多态性与中国北方汉族人再生障碍性贫血（AA）的相关性。方法应用顺序特异性引物和聚合酶链反应（PCR-SSP）技术,检测了36例AA患者（再障组）和40例健康献血者（对照组）中IL-6基因位点的多态性变化。结果结果表明IL-6基因-174G/C多态性位点基因型频率和等位基因频率在两组人群中的分布差异有统计学意义（χ2=6.31,P〈0.05）,G等位基因携带者患AA的风险是C等位基因的3.74倍（OR=3.7405）。两组之间比较差异有显著性意义,提示该等位基因频率增高与AA相关。结论IL-6基因-174G/C多态性与AA的发病具有相关性,其中G等位基因可能是我国北方汉族人AA发病的遗传易感基因,携带G等位基因的个体可能通过促进IL-6的高度表达进而增加AA的发病风险。     

IL-1、IL-10及TNF-β单核苷酸多态性与福建泉州地区汉族人群类风湿性关节炎的相关性研究

目的:探讨福建泉州地区汉族人群类风湿性关节炎(RA)患者炎症相关因子的单核苷酸多态性(SNP)位点的分布特征,并研究其与RA易感性的关系。方法:选取福建泉州地区汉族人群RA患者155例(RA组)和健康体检者170例(对照组)为研究对象,采用全血三引物等位基因特异性扩增(TRIP-ASPCR)技术对RA相关的SNP位点进行基因分型。运用SPSS 19.0统计分析软件,采用卡方检验和Logistic法分析Hardy-Weinberg遗传平衡吻合度、SNP位点等位基因与RA发病关联强度,并利用SHEsis软件对所选SNP位点进行连锁不平衡分析和单倍型分析。结果:对照组中有1个SNP位点符合Hardy-Weinberg平衡检验(P>0.05),RA组有1个SNP位点符合Hardy-Weinberg平衡检验(P>0.05);在对照组和RA组之间有4个SNP位点的等位基因频率差异存在统计学意义(P<0.05,OR>1),与RA呈正相关,且相关性明显。结论:RA患者中,存在4个SNP位点(IL-10 rs1800893、IL-1βrs16944、TNF-βrs2009658和TNF-βrs1041981)与福建泉州地区汉族人群的RA呈正相关,且相关性明显;各位点分别对应的等位基因G、G、C和C可能作为福建泉州地区汉族人群RA的一个潜在遗传标志。     

Interleukin-18基因启动子区单核苷酸多态性与肝细胞癌遗传易感性关系的研究

目的探讨白细胞介素18(IL-18)基因启动子区-607C/A(rs1946518)和-137G/C(rs187238)单核苷酸多态性(SNP)与肝细胞癌(肝癌)遗传易感性的关系。方法应用序列特异性引物-聚合酶链反应(PCR-SSP)技术,检测228例肝癌患者和300例健康对照者IL-18基因启动子-607C/A(rs1946518)、-137G/C(rs187238)单核苷酸多态性位点基因型,分析肝癌患者和对照组基因型频率和等位基因频率分布。结果肝癌组SNP位点rs187238 G等位基因的频率明显高于对照组(OR=1.1891,95%CI=1.0106-1.5633,P=0.026)。携带rs187238 GG基因型的肝癌患者较多(OR=1.5168,95%CI=1.1490-1.8322,P=0.010)。分层分析发现,rs1946518位点上AA基因型与肝癌发病的关联在饮酒的肝癌患者中更加显著(P=0.024),而且rs187238位点上GC/CC基因型与肝癌发病的关联在出现肝癌复发的患者中更加显著(P=0.005)。结论 IL-18基因启动子区-137G/C(rs187238)GG基因型与肝癌遗传易感性有关联。而rs1946518位点AA基因型和rs187238位点GC/CC基因型分别与肝癌患者饮酒和肝癌复发有关联。     

CYP1B1基因多态性与子宫内膜异位症易感性的相关研究

目的 研究CYP1B1基因第2外显子119(G-T)、第3外显子432(C-G)多态性与子宫内膜异位症(endometriosis,Ems)易感性的关系.方法 采用等位基因特异性聚合酶链反应对55例Ems患者和45例对照组进行CYP1B1基因第2外显子119(G-T)、第3外显子432(C-G)突变分析,探讨Ems的发生与CYP1B1基因多态性之间的相关性.结果 CYP1B1基因密码子119中等位基因G、T在Ems组和对照组分布的差异有统计学意义(P＜0.05),其中等位基因T使Ems发病风险提高2.061倍;CYP1B1基因密码子119G/T各基因型分布两组间差异有统计学意义(P＜0.05),纯合突变(T/T)基因型、杂合突变(G/T)基因型与野生型(G/G)基因型相比,患Ems的危险度分别为2.625倍和3.214倍.以CYP1B1联合野生型GG和CC个体的OR值为1相比,CYP1B基因密码子119杂合型突变(Ala/Ser)合并密码子432野生型个体的OR值为2.976,95%CI:1.129～7.848,P＜0.05.结论 CYP1B1基因第2外显子119(G-T)突变等位基因与Ems的发生有一定关系,突变基因型增加了Ems的发病风险;CYP1B1基因第2外显子杂合型突变(Ala/Ser)联合密码子432野生型能增加Ems的发病风险.     

Synergistic effect of interleukin-6 promoter (IL6 -634C/G) and intercellular adhesion molecule-1 (ICAM-1 469K/E) gene polymorphisms on the risk of endometriosis in Japanese women

PROBLEM: Endometriosis is an immune-related, chronic inflammatory disease with a polygenic predisposition. The aim of this study was to investigate whether the interleukin-6 (IL-6) gene promoter region polymorphism (-634C/G) and the intercellular adhesion molecule-1 (ICAM-1) gene 469K/E polymorphism are responsible in part for the genetic susceptibility to endometriosis. METHODS OF STUDY: The IL-6 -634C/G and ICAM-1 469K/E genotypes were determined in 202 patients with endometriosis and 236 control women by polymerase chain reaction-restriction fragment length polymorphism. RESULTS: There were no differences in the IL-6 -634C/G or the ICAM-1 469K/E genotypes and allele frequencies between control women and endometriosis patients collectively, or between control women and each clinical subgroup of endometriosis patients. Interestingly, the frequency of ICAM-1 EE homozygotes who concomitantly carried the IL-6 -634G allele was significantly higher in patients with endometriosis (chi(2) = 6.458, P = 0.0396, d.f. = 2). CONCLUSION: Our results suggest that the IL-6 -634C/G and ICAM-1 469K/E polymorphisms synergistically affect the susceptibility for endometriosis in the Japanese population.     

Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis

Interleukin-6 (IL-6) is a multifunctional cytokine produced by different cell types, including monocytes, lymphocytes, endothelial and mesangial cells. Deregulated production of IL-6 was found to be involved in mesangial proliferative glomerulonephritis. We investigated whether the single nucleotide polymorphism (SNP) in the promoter region of the IL-6 gene is associated with a development of chronic glomerulonephritis (CGN). The study group consisted of 541 patients with CGN. Of those 338 already progressed to ESRD. The control group involved 253 healthy individuals. All subjects were genotyped for the -634 C/G polymorphism of the IL-6 gene by polymerase chain reaction (PCR). PCR product was digested with BsrBI restriction endonuclease and analyzed on 3% agarose. The allele and genotype frequencies were similar between CGN patients in a pre-dialysis stage and control subjects. Significantly increased frequency of the G allele was observed in the ESRD patients (13% vs. 6% in pre-dialysis stage, P < 0.01). After dividing ESRD patients according to time from reported disease onset to ESRD, those with time < or =5 years showed even higher G allele frequency (21% vs. 13% in entire ESRD group). Interestingly, most of the GG homozygotes were in this faster progressing group. Both subgroups were comparable for sex, age, BMI, total cholesterol and serum creatinine. The multivariate logistic regression analysis revealed that the IL-6 genotype with the G allele was an independent risk factor of progression to ESRD (P < 0.001). Our results indicate that the IL-6 -634 G/C polymorphism may be a possible risk factor for faster progression of chronic glomerulonephritis to ESRD. It is also possible that this polymorphism is in linkage disequilibrium with another functional polymorphism in the II-6 gene or its vicinity.     

Association of IL-6 gene polymorphisms with cachexia susceptibility and survival time of patients with pancreatic cancer

The purpose of this study was to determine the predictive value of IL-6-572, -190, and -634 gene polymorphisms on the cachexia susceptibility and survival time of patients with pancreatic cancer. Genotypes were determined using restriction fragment length polymorphism analysis of polymerase chain reaction products. All of the subjects were homozygous to the C allele of IL-6-190. No significant differences were found in the IL-6-572G and -190C distributions between the cachexia group and the non-cachexia group. Patients with cachexia showed significantly higher prevalence of common bile duct obstruction (CBD) than those without (p = 0.026). A significantly increased frequency of the IL-6-634G allele was noted in the cachexia group vs the non-cachexia group (p = 0.021). Logistic regression adjusted for sex, age, duodenal obstruction, and CBD obstruction, the IL-6-634 CG + GG genotype was associated with an odds ratio of 2.785 (1.034, 7.501) for cachexia. Patients with IL-6-634 CG + GG carrier showed shorter duration of survival than those with CC genotype (p = 0.023). These results indicate that the IL-6-634G allele is associated with increased susceptibility to cachexia and decreased survival time of Chinese patients suffering from pancreatic cancer.     

Association between VEGF polymorphisms (936c/t, -460t/c and -634g/c) with haplotypes and coronary heart disease susceptibility

Aim: Our aim was to investigate the association between single nucleotide polymorphisms (SNPs) of vascular endothelial growth factor (VEGF) and coronary heart disease (CHD) susceptibility in Chinese Han population. Methods: 144 CHD patients and 150 healthy individuals were enrolled in the study. Three SNPs (936C/T, -460T/C and -634G/C) of VEGF were chose and then were genotyped with Sequenom time-of-flight mass spectrometry (TOFMS). Odds ratio (OR) with 95% confidence interval (CI) were used to evaluate the association of genotypes and haplotypes and CHD susceptibility. Results: The frequencies of -460T/C CC genotype (13.6%) was found higher in the case group than that of control group (6.7%), which indicated that CC genotype was a risk factor for CHD (OR=2.50, 95% CI=1.10-5.68). Correspondently, the C allele appeared to increase the risk of CHD (OR=1.54, 95% CI=1.07-2.22). For -634G/C polymorphism, the risk of the CC genotype carrier for CHD increased 2.24 fold compared to the wild genotype. Moreover, -634G/CC allele was significantly associated with CHD susceptibility (OR=1.65, 95% CI=1.15-2.36). In addition, +936C/T CT genotype and C allele appeared to be a genetic-susceptibility factors for CHD (OR=2.43, 95% CI=1.44-4.10; OR=1.95, 95% CI=1.26-3.02). The haplotype analysis showed that T-C-T, C-C-C and C-G-C haplotypes all could increase the risk for CHD (OR: 2.43, 2.77 and 2.33). Conclusion: we concluded VEGF polymorphisms were associated with CHD susceptibility. Moreover, the haplotypes of T-C-T, C-C-C and C-G-C all could increase the risk for CHD.     

Association of IL-1β and IL-6 gene polymorphisms with recurrent spontaneous abortion in a Chinese Han population

As certain cytokines may play a role in unexplained recurrent spontaneous abortion (RSA) and also some cytokine gene polymorphisms may affect the level of cytokine production, the aim of this study was to investigate the relationship between Chinese RSA and polymorphisms of the genes coding for interleukin (IL)-1β (-31C/T, -511C/T, +3954C/T) and IL-6 (-634C/G). Women (n = 162) with at least three consecutive spontaneous abortions and 156 ethnically matched healthy women with at least one successful pregnancy were included. Genotypes were determined using restriction fragment length polymorphism analysis of polymerase chain reaction products. No significant differences were found in the IL-1β-31T, -511T and +3954T distributions between the RSA group and the control group. On the other hand, the frequencies of the IL-6-634GG genotype and -634G allele were significantly decreased in the RSA group versus the control group (genotype: P = 0.0003; allele: P = 0.002), suggesting the IL-6-634C/G polymorphism might be a possible genetic protective factor for RSA.     

白细胞介素6与钙感应性受体基因多态性对青春期女童骨量增长的交互作用

目的 探讨白细胞介素6(interleukin-6,IL-6)与钙感应性受体(calcium sensing receptor,CASR)基因多态性对青春期女童骨量增长的交互作用.方法 选择228名9-11岁半未月经初潮的健康女童进行两年追踪,采用双能X线骨密度仪检测对象追踪前后全身、左侧近端股骨(包括股骨颈、大转子、粗隆间和华氏三角区)和L1-L4腰椎骨矿含量(bone mineral content,BMC)和骨密度(bone mineral density,BMD),采用聚合酶链反应-限制性片段长度多态性技术检测IL-6-634C/G位点多态性,等位基因特异性突变分离扩增-PCR技术检测CASR A986S位点多态性.结果 176名女童完成整个研究.IL-6基因-634C/G和CASR基因A986S位点多态性与青春期女童骨量增长有关联,IL-6基因-634C/G位点CG+GG基因型女童全身和股骨大转子BMD较CC基因型分别低25.7%和20.6%,CASR基因A986S位点AS+SS基因型女童L1.L4腰椎BMC和华氏三角区BMD增长率较AA基因型分别低14.9%和51.3%,差异有统计学意义(P＜0.05).交互作用分析发现,同时具有IL-6基因-634C/G位点G等位基因和CASR基因A986S位点S等位基因的女童,其股骨颈和L1-L4腰椎BMC增长率最低.结论 同时具有IL-6基因-634C/G位点G等位基因和CASR基因A986S位点S等位基因的女童,可能是低骨量增长的危险人群.     

Significant Impact of IL-6 -174G/C but Inverse Relation with -634 C/G Polymorphism in Patients with Non-Small Cell Lung Cancer in Kashmiri Population

To study the possible role of proinflammatory interleukin 6 -174 G>C (rs 1800795) and -634 C>G (rs 1800796) polymorphism in the pathogenesis of non-small cell lung cancer (NSCLC). A total of 190 NSCLC patients and 200 healthy controls were evaluated for polymorphic analysis of -174 G/C and -634 C/G by PCR-RFLP followed by DNA sequencing. A significant association was observed in the genotypic and allelic distribution of IL-6 -174 G/C in the NSCLC group as compared to control group [OR?=?2.7 (1.77–4.11), p?<?0.0001]. Smokers with the -174C allele were found to be significantly associated with NSCLC (p?=?0.01), while 634C/G SNP showed an inverse relation [OR-0.4, p?<?0.0001]. The present investigation revealed a significant association of the IL6 -174 G/C gene promoter polymorphism with NSCLC, and thus, the IL-6 -174G/C genotype can be considered as one of the biological markers in the etiology of NSCLC.     

脂联素基因SNP+45 T/G单核苷酸多态性与冠心病的相关性研究

目的:研究中国华南地区汉族人脂联素基因SNP+45T/G单核苷酸多态性与冠心病的相关性。方法:以153例冠脉造影证实为冠心病的非糖尿病患者为冠心病组,以73例健康者为对照组,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法分析脂联素基因SNP+45T/G单核苷酸多态性与冠心病的相关性,ELISA法测定血浆脂联素水平。结果:冠心病组T/G+G/G型频率、G等位基因频率均高于对照组(P0.05)。Logistic回归分析发现脂联素基因SNP+45 T/G+G/G型与冠心病正相关(OR:2.132,95.0%C I:1.034-4.397,P0.05),血浆脂联素水平与冠心病的发病呈负相关(OR:0.868,95.0%C I:0.785-0.959,P0.05)。结论:脂联素基因SNP+45 T/G+G/G型可能是华南地区汉族人冠心病的易感基因型。     

Interleukin 6-174 G/C promoter polymorphism and pregnancy complications: results of a prospective cohort study in 1626 pregnant women.

PROBLEM: To investigate the frequency of the interleukin-6 (IL-6) -174 G/C single nucleotide polymorphism (SNP) in women with intrauterine fetal death (IUFD), pre-eclampsia (PE), preterm delivery (PD), and small for gestational age (SGA) infants. METHOD OF STUDY: In a prospective cohort study, DNA from 1626 consecutive pregnant women was analyzed for IL-6 -174 G/C. Women who developed at least one of the predefined pregnancy complications were used as cases and compared with women without pregnancy complications. RESULTS: Of 1626 women, 259 (15.9%) developed at least one pregnancy complication. IL-6 -174 G/C allele frequencies and genotype distributions were not significantly different between cases and controls. Similarly, no statistically significant difference in IL-6 -174 G/C genotype distribution in women with IUFD, PE, PD <34 weeks, PD >34 weeks and SGA infants <10th percentile was observed. CONCLUSION: IL-6 -174 G/C is not a genetic marker for identifying women at increased risk of common pregnancy complications.